Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites.
about
Agonist-induced increase in apparent beta-adrenergic receptor size.Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failureDesensitization of the beta-adrenoceptor of lymphocytes from normal subjects and asthmatic patients in vitro.beta-adrenergic receptors in rat liver: effects of adrenalectomyDesensitization of beta-adrenergic receptors by beta-adrenergic agonists in a cell-free system: resensitization by guanosine 5'-(beta, gamma-imino)triphosphate and other purine nucleotides.Modulation of acetylcholine receptor by antibody against the receptor.Rapid changes in rat pineal beta-adrenergic receptor: alterations in l-(3H)alprenolol binding and adenylate cyclase.Effects of drugs affecting endogenous amines or cyclic nucleotides on ethanol withdrawal head twitches in mice.The lymphocyte beta-adrenoceptor in normal subjects and patients with bronchial asthma: the effect of different forms of treatment on receptor functionIncreased insulin binding by hepatic plasma membranes from diabetic rats: normalization by insulin therapy.Influence of biogenic amines on the growth of xenografted human colorectal carcinomas.Membrane receptors for hormones and neurotransmitters.Cellular mechanisms of impaired adrenergic responsiveness in neonatal dogs.Beta adrenergic and muscarinic cholinergic receptors in canine myocardium. Effects of ischemiaThe impact of streptozotocin-induced diabetes mellitus on cyclic nucleotide regulation of skeletal muscle amino acid metabolism in the rat.The regulation of skeletal muscle alanine and glutamine formation and release in experimental chronic uremia in the rat: subsensitivity of adenylate cyclase and amino acid release to epinephrine and serotonin.Bihormonal regulation of the thyrotropin-releasing hormone receptor in mouse pituitary thyrotropic tumor cells in culture.Hormonal control of adrenocortical cell proliferation. Desensitization to ACTH and interaction between ACTH and fibroblast growth factor in bovine adrenocortical cell cultures.Parathyroid hormone responses to catecholamines and to changes of extracellular calcium in cows.Evidence for internalization of the recognition site of beta-adrenergic receptors during receptor subsensitivity induced by (-)-isoproterenol.Catecholamine binding to the beta-adrenergic receptor.Gonadotropin-induced regulation of luteinizing hormone receptors and desensitization of testicular 3':5'-cyclic AMP and testosterone responsesDifferential desensitization of functional adrenergic receptors in normal and malignant myeloid cells: relationship to receptor-mediated hormone cytotoxicity.Properties of muscarinic acetylcholine receptors in heart cell cultures.Unmasking of magnesium-dependent high-affinity binding sites for [dAla2, dLeu5]enkephalin after pretreatment of brain membranes with guanine nucleotides.New insights in the pathogenesis of atopic disease.The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.In vivo labelling of beta-adrenergic receptors on rat glioma cells.The metabolic, stress axis, and hematology response of zilpaterol hydrochloride supplemented beef heifers when exposed to a dual corticotropin-releasing hormone and vasopressin challenge.Desensitization of beta-adrenergic receptors of glioma cells: studies with intact and broken cell preparations.Radioligand binding studies of adrenergic receptors and their clinical relevance.Plasma membrane receptors.Sympathetic control of the renal circulation.Cytoskeleton regulates beta-adrenergic hormonal stimulation in normal and leukemic white blood cells.Uncoupling and endocytosis of 5-hydroxytryptamine 4 receptors. Distinct molecular events with different GRK2 requirements.Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol.Pharmacokinetics and pharmacodynamics in the critically ill patient.Time couse of the blockade effect of propranolol on sinus node and atrioventricular node.The regulation of delta-opiate receptor density on 108CC15 neuroblastoma X glioma hybrid cells.The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine.
P2860
Q33955321-D295312F-3ED3-4B33-B6EA-8B240ECF8F44Q34397513-AB6F0216-0037-4EA0-9E85-E5E5938BE504Q34516306-C186D4AC-4712-4E5C-8464-6900712AC2E7Q34998708-071DE094-7F1A-41CB-9AA9-9DDC08051231Q35000804-F99B2D54-A408-4306-9FFF-C250A8D3D3F3Q35039206-516B1C5D-72C4-42F1-A165-24B2AC88FEADQ35089912-5549333D-1E14-45C7-BACF-A4FF693414E1Q35176148-C2284DA8-FBC2-4719-8014-85854F80DDEAQ35905267-05F25554-2740-4E21-AB30-EC818294472FQ35905428-1AD9082A-C518-4A63-88E5-E8BFE72C466EQ36043540-1DDA1834-777A-4F7F-9038-20439A75EB5BQ36198388-5A7C87E0-B751-447A-8706-825405687A59Q36995062-77A406E3-A382-47D6-880D-F98B19722E23Q37017720-1EE32436-E330-426B-9A5D-177CC0647364Q37020640-84168020-C339-4492-94A1-ABD0F68A2599Q37031651-5954A10D-DA30-4105-A3EE-44F5B44E2058Q37032876-53BA7959-1FC5-49D0-A544-E1FE0B4FA2D3Q37045934-1ABFD2B3-426D-45E4-AA6D-B973890AF262Q37053333-E80C127C-B894-4BF7-8B21-697F5C256444Q37334542-FC5FC685-2539-4ACF-81F5-ACE96388C1BEQ37581625-B76F83A4-AA79-4BB4-A7F7-F86C98674C5DQ37581941-07B0B83C-A3BB-4AD0-9041-46DF8C02A449Q37583539-648A28C0-7BF6-427E-914C-7C1F37874B86Q37595690-A6E5C417-3491-40F4-8ABC-213571B859A3Q37603680-02CEDDDB-5FAB-41BB-81C6-5A33C13BFF34Q37682804-7CEA6CC0-FF64-4293-8E5E-736209E30091Q38365784-D1559E17-088E-4C94-847C-269B68D2A6AFQ39148008-979B0A94-E88F-4AE0-9BFF-726C49F8AB42Q39534399-5C6F1D31-5A35-44D2-A8BE-0CFB8319D0C6Q40007705-09154721-3F0E-4B8C-A0C2-1AB20FDA2AECQ40125199-4CB34C9E-3AFC-4E83-B2D8-AD0342EDD5C2Q40137963-7972FBB3-39F8-45AD-98C7-0350AA27206DQ40149755-8226093B-C993-49F7-B38B-45067D7BBDECQ40151700-927C73B1-BC69-4455-B529-88C533AA8EDBQ40416635-CC0056A4-05C2-4A6E-9FF1-A0D2BF8C231AQ40683665-B1D94A56-8E72-452B-9B7E-BB7D9C74F8E0Q40815584-5C7D7CE5-1F6D-4749-92BE-40CC2310E877Q41452766-0B89D149-778F-423F-80D6-007714495084Q41745483-1C324971-F811-486E-AC57-17488ACF0185Q41813071-2FA0DF01-0F6F-418C-8027-A05954F3C9E9
P2860
Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites.
description
1975 nî lūn-bûn
@nan
1975 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Catecholamine-induced subsensi ...... nergic receptor binding sites.
@ast
Catecholamine-induced subsensi ...... nergic receptor binding sites.
@en
Catecholamine-induced subsensi ...... nergic receptor binding sites.
@nl
type
label
Catecholamine-induced subsensi ...... nergic receptor binding sites.
@ast
Catecholamine-induced subsensi ...... nergic receptor binding sites.
@en
Catecholamine-induced subsensi ...... nergic receptor binding sites.
@nl
prefLabel
Catecholamine-induced subsensi ...... nergic receptor binding sites.
@ast
Catecholamine-induced subsensi ...... nergic receptor binding sites.
@en
Catecholamine-induced subsensi ...... nergic receptor binding sites.
@nl
P2093
P2860
P356
P1476
Catecholamine-induced subsensi ...... nergic receptor binding sites.
@en
P2093
Lefkowitz RJ
Mukherjee C
P2860
P304
P356
10.1073/PNAS.72.5.1945
P407
P577
1975-05-01T00:00:00Z